Hualan Vac: The industry in which the company operates is the human vaccine manufacturing industry, with the main product being the quadrivalent influenza virus vaccine, which is used to prevent influenza caused by the influenza virus. Currently, the company does not have any vaccine products for the prevention of Nipah virusWallstreetcn·Jan 27 at 04:29 AM301207+1.67%
Afternoon flu concept shows partial fluctuations, Hualan Vac rises over 10%Zhitong·Nov 3, 2025 at 11:44 PM002007-0.30%301207+1.67%
Hualan Vac released its performance for the first three quarters, with a net profit attributable to the parent company of 132 million yuan, a decrease of 50.51%Zhitong·Oct 29, 2025 at 05:47 AM301207+1.67%
Overview of A-share dividends and stock distributions: 9 stocks have their equity registration todayZhitong·Oct 23, 2025 at 06:54 PM002007-0.30%301207+1.67%
Overview of the lifting of restrictions on the circulation of A-shares | August 18Zhitong·Aug 17, 2025 at 08:02 PM301207+1.67%0005910.00%
Overview of A-share lock-up stock release: Lock-up stocks worth 46.718 billion yuan are released todayZhitong·Aug 17, 2025 at 06:34 PM688728+1.91%301207+1.67%
Next week, 25 stocks will have their restrictions lifted. Based on the latest closing prices, the total market value of the lifted restrictions is 79.529 billion yuan. United Imaging Healthcare will have 231 million shares listed for circulation next week, mainly consisting of original shareholders' restricted shares from the initial public offering, with a market value of 29.541 billion yuan. GCORE's scale of lifted restrictions is second, with 1.05 billion shares listed for circulation next week, primarily consisting of original shareholders' restricted shares from the initial public offering, with a market value of 16.391 billion yuan. In terms of the lifting ratio, Hualan Vac has the highest lifting ratio at 76.37%, followed by Zhongchu Media, GCORE, Luwei Optoelectronics, and Huicheng Co., LtdZhitong·Aug 15, 2025 at 09:31 AM688728+1.91%301207+1.67%
Hualan Vac: The freeze-dried type B influenza Haemophilus influenzae conjugate vaccine has obtained the drug clinical trial approval noticeZhitong·Aug 13, 2025 at 02:59 AM301207+1.67%
Hualan Vac: Currently focused on the research and production of human vaccinesZhitong·May 21, 2025 at 02:27 AM301207+1.67%
Hualan Vac released its first-quarter performance, with a net profit attributable to the parent company of 32.7771 million yuan, a year-on-year decrease of 15.06%Zhitong·Apr 27, 2025 at 05:57 AM301207+1.67%
Hualan Vac released its 2024 annual performance, with a net profit attributable to the parent company of 206 million yuan, a decrease of 76.10%Zhitong·Mar 28, 2025 at 07:13 AM301207+1.67%
Kuo Kuang Biotechnology collaborates with the South Link Foundation to deliver flu vaccines to rural areas in Taitungmoney.udn.com·Feb 17, 2025 at 01:20 AM301207+1.67%
Hualan Vac: 2024 net profit is expected to decrease by 70.93% to 76.74% year-on-yearZhitong·Jan 16, 2025 at 03:01 AM301207+1.67%
Hualan Vac issued a profit warning, expecting a net profit of 200 million to 250 million yuan for the fiscal year 2024, a decrease of 70.93% to 76.74%Zhitong·Jan 16, 2025 at 02:04 AM301207+1.67%
